PubMed Health⌕ Search

Biomedical subjects

C Wypijewski

Publications and source records attributed to C Wypijewski.

2 recordsLinked to original sources

The effects of gonadectomy on glucose tolerance of genetically obese (fa/fa) rats: influence of sex and genetic background.

In both humans and rodents the occurrence and severity of obesity-associated non-insulin dependent diabetes mellitus (NIDDM) may be influenced by both gonadal hormones and genetic background. Early gonadectomy (at 3-5 days of age) of female and male Wistar diabetic fatty (WDF) rats and of male Zucker rats allowed us to examine these effects in genetically obese rats carrying the fatty (fa) gene. Impairment of glucose tolerance and insulin sensitivity by obesity, and amelioration or exacerbation (in the case of female rats) of this impairment by gonadectomy were assessed by intragastric glucose tolerance tests when the rats reached adulthood. Both glucose tolerance and insulin sensitivity were significantly deranged in obese WDF rats of both sexes and in obese male Zucker rats compared to lean controls of the same sex and strain. Obese male WDF rats were less glucose tolerant and insulin sensitive than were obese male Zucker rats. Glucose intolerance was not ameliorated by castration in lean or obese male WDF or Zucker rats. Insulin sensitivity was significantly improved by castration in obese male rats of both strains, as fasting plasma insulin levels and total areas under the insulin curves were significantly reduced compared to obese sham-operated controls. This effect was greater in the Zucker than in the WDF male rats. Castration significantly decreased the insulin response areas in obese male Zucker rats, but did not alter those of the obese male WDF rats. Ovariectomy did not alter glucose homeostasis of obese female WDF rats.(ABSTRACT TRUNCATED AT 250 WORDS)

Animals↗

Objectives for the year 2000.

The Healthy People 2000 initiative challenges the United States to improve the health profile of Americans through a prevention agenda targeting improvements in health status and health service delivery and reduction of risk for disease and disability. Clinical laboratories play an important role in achieving these national health goals and objectives. Many specific objectives directly target improved laboratory services, whereas others are fundamentally dependent on access to better laboratory services. The effectiveness of preventive services (i.e., screening tests, immunizations, and counseling) in reducing morbidity and mortality is well documented. In addition to ensuring quality laboratory services through accurate and reliable screening tests, a unique challenge for clinical laboratories is meeting the critical need for improving communication of complete and necessary laboratory information among laboratories, providers, and patients to enhance patient counseling. The challenges facing clinical laboratories as we approach the year 2000 are complex, but the commitment of the laboratory community is essential.

Delivery of Health Care↗